Information Provided By: 
Fly News Breaks for December 6, 2019
EW
Dec 6, 2019 | 09:15 EDT
Canaccord analyst Jason Mills said he likes the set up for Edwards Lifesciences heading into 2020. He said management's guidance is solid across the board and he believes it will be an auspicious year for the company. He would buy the shares on any pullback. Mills reiterated his Buy rating and $260 price target on Edwards Lifesciences shares.
News For EW From the Last 2 Days
There are no results for your query EW
